Extracellular Matrix-Related Six-lncRNA Signature as a Novel Prognostic Biomarker for Bladder Cancer.
Liangliang QingPeng GuMingsheng LiuJihong ShenXiaodong LiuRunyun GuangKunbin KeZhuo HuangWen-Hui LeeHui ZhaoPublished in: OncoTargets and therapy (2020)
Our study revealed that the lncRNA signature is an important predictive factor of prognosis and provides a promising biomarker for BC.